Press release:
ValitaCell, the biotechnology company accelerating the manufacture of biotherapeutics, announced today that they are launching the Valita®Titer PLUS assay at the upcoming Bioprocessing International Europe event. The extended range of the Quantum platform – Valita®Titer PLUS – can measure protein titer concentration across a wide dynamic range – while maintaining accuracy and speed.
Every day, researchers ask themselves a key question about their samples: How much protein titer do I have? To get the answers, they typically need to run experiments on specialised instruments which wastes valuable time and sample. Valita®Titer PLUS now offers scientists a solution to measure antibody titer across a much wider dynamic range, from the same low-volume sample.
The Valita®Titer range of assays deliver the best of three key attributes — accuracy, simplicity and speed. With just 5 µL, Valita®Titer PLUS quantifies concentration in less than 2.5 minutes on a plate reader across concentrations of 50 – 2000 mg/L. Researchers working with a full plate can quantify 96 samples in less than 45 minutes. For heavy duty workflows, users can connect to a liquid handler to eliminate hands-on time.
“We are delighted to bring this product to the market, which delivers IgG antibody protein quantification across a much broader dynamic range,” said Jerry Clifford, COO at ValitaCell. “Antibody titer is a key parameter that researchers must measure. Valita®Titer PLUS allows researchers to do this in a simple, speedy and high-throughput manner.”
